Improvement in HOMA-IR is an independent predictor of reduced carotid intima-media thickness in obese adolescents participating in an interdisciplinary weight-loss program

Hypertension Research

Volumn 34, Issue 2, 2011, Pages 232-238

  De Lima Sanches, Priscila ^a   De Mello, Marco Tlio ^a   Elias, Natália ^a   Fonseca, Francisco Antonio Helfenstein ^a   De Piano, Aline ^a   Carnier, June ^a   Oyama, Lila Missae ^a   Tock, Lian ^a   Tufik, Sergio ^a   Dâmaso, Ana Raimunda ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

adiponectin; atherosclerosis; inflammation; obesity; PAI 1

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLASMINOGEN ACTIVATOR INHIBITOR;

ADOLESCENT; ADULT; AEROBIC EXERCISE; ARTERIAL WALL THICKNESS; ARTICLE; BLOOD PRESSURE; BODY COMPOSITION; CALORIC INTAKE; CARDIOVASCULAR RISK; CAROTID ARTERY; CLINICAL ARTICLE; COMMON CAROTID ARTERY; DIET THERAPY; ECHOGRAPHY; FEMALE; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; HOMEOSTASIS MODEL ASSESSMENT; HUMAN; INFLAMMATION; INSULIN RESISTANCE; INSULINEMIA; MACRONUTRIENT; MALE; OBESITY; PSYCHOTHERAPY; RESISTANCE TRAINING; WEIGHT REDUCTION;

ADIPOKINES; ADIPONECTIN; ADOLESCENT; BLOOD GLUCOSE; BLOOD PRESSURE; BRAZIL; CARDIOVASCULAR DISEASES; DIET, REDUCING; EXERCISE; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; LIPIDS; MALE; OBESITY; PLASMINOGEN ACTIVATOR INHIBITOR 1; PSYCHOTHERAPY; TUNICA INTIMA; WEIGHT LOSS;

EID: 79751486125     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2010.225     Document Type: Article

References (37)

1. Caranti DA, Lazzer S, Dâmaso AR, Agosti F, Zennaro R, de Mello MT, Tufik S, Sartorio A. Prevalence and risk factors of metabolic syndrome in Brazilian and Italian obese adolescents: a comparison study. Int J Clin Pract 2008; 10: 1526-1532.
2. Oda E. The metabolic syndrome as a concept of adipose tissue disease. Hypertens Res 2008; 31: 1283-1291.
3. Rodrigues AN, Perez AJ, Pires JG, Carletti L, Araú jo MT, Moyses MR, Bissoli NS, Abreu GR. Cardiovascular risk factors, their associations and presence of metabolic syndrome in adolescents. J Pediatr 2009; 85: 55-60.
4. Järvisalo MJ, Jartti L, Näntö-Salonen K, Irjala K, Rönnemaa T, Hartiala JJ, Celermajer DS, Raitakari OT. Increased aortic intima-media thickness: a marker of preclinical atherosclerosis in high-risk children. Circulation 2001; 104: 2943-2947. (Pubitemid 33139107)
5. Reinehr T, Kiess W, de Sousa G, Stoffel-Wagner B, Wunsch R. Intima-media thickness in childhood obesity. Relations to inflammatory marker, glucose metabolism, and blood pressure. Metab Clin Exp 2006; 55: 113-118. (Pubitemid 41736256)
6. Beauloye V, Zech F, Tran HT, Clapuyt P, Maes M, Brichard SM. Determinants of early atherosclerosis in obese children and adolescents. J Clin Endocrinol Metab 2007; 92: 3025-3032. (Pubitemid 47236366)
7. Shargorodsky M, Boaz M, Goldberg Y, Matas Z, Gavish D, Fux A, Wolfson N. Adiponectin and vascular properties in obese patients: is it a novel biomarker of early atherosclerosis? Int J Obesity 2009; 33: 553-558.
8. Bruun JM, Lihn AS, Verdich C, Pedersen SB, Toubro S, Astrup A, Richelsen B. Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans. Am J Physiol Endocrinol Metab 2003; 285: E527-E533. (Pubitemid 37010830)
9. Goldstein BJ, Scalia R. Adiponectin: a novel adipokine linking adipocytes and vascular function. J Clin Endocrinol Metab 2004; 89: 2563-2568. (Pubitemid 38766332)
10. Muniyappa R, Lantorno M, Quon MJ. An integrated view of insulin resistance and endothelial dysfunction. Endocrinol Metab Clin N Am 2008; 37: 685-711.
11. Rodriguez RR, Gómez-D́az RA, Haj JT, Garnica FJA, Soriano ER, Meguro EN, Aguilar- Salinas CA, Wacher NH. Carotid intima-media thickness in pediatric Type 1 diabetic patients. Diabetes Care 2007; 30: 2599-2602. (Pubitemid 47547803)
12. Kim K, Valentine RJ, Shin Y, Gong K. Associations of visceral adiposity and exercise participation with C-reactive protein, insulin resistance, and endothelial dysfunction in Korean health adults. Metabolism 2008; 57: 1181-1189.
13. Hadi HAR, Car CS, Suwaidi JA. Endothelial dysfunction: cardiovascular risk factors, therapy and outcome. Vasc Health Risk Managem 2005; 1: 183-198.
14. Woo KS, Chook P, Yu CW, Sung RYT, Qiao M, Leung SSF, Lam CWF, Metreweli C, Celermajer DS. Effect of diet and exercise on obesity related vascular dysfunction in children. Circulation 2004; 109: 1981-1986. (Pubitemid 38544488)
15. Wunsch R, de Sousa G, Toschke AM, Reinehr T. Intima-media thickness in obese children before and after weight loss. Pediatr 2006; 118: 2334-2340. (Pubitemid 46397571)
16. Tanner JM, Whitehouse RH. Clinical Longitudinal standards for height, weight, weight velocity and stages of puberty. Arch Dis Child 1976; 51: 170-179.
17. Centers for Disease Control and Prevention. Hyattsville: National Center for Health Statistics. (Updates on 11 January 2007; accessed on 15 August 2007). Prevalence of overweight among children and adolescents: United States 1999-2002. http:// www.cdc.gov/nchs/products/pubs/pubd/hestats/overwght99.htm.
18. Ribeiro-Filho FF, Faria NA, Azjen S, Zanella MT, Ferreira SR. Methods of estimation of visceral fat: advantages of ultrasonography. Obes Res 2003; 11: 1488-1494. (Pubitemid 41127333)
19. Guardamagna O, Abello F, Saracco P, Baracco V, Rolfo E, Pirro M. Endothelial activation, inflammation and premature atherosclerosis in children with familial dyslipidemia. Atherosclerosis 2009; 207: 471-475.
20. Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005; 115: e500-e503.
21. Giuliano ICB, Caramelli B, Pellanda L, Duncan B, Mattos S, Fonseca FAH. I Guideline for preventing atherosclerosis in childhood and adolescence. Int J Atheroscler 2006; 1: 1-30.
22. World Health Organization (WHO). Report of a WHO consultation. In: Alwan A, King H (eds). Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications. Part 1: Diagnosis and Classification of Diabetes Mellitus. Department of Noncommunicable Disease Surveillance, World Healthy Organization: Geneva, 1999, pp 1-59.
23. Donnelly JE, Blair SN, Jakicic JM, Manore MM, Rankin JW, Smith BK. Appropriate physical activity intervention strategies for weight loss and prevention of weight regain for adults. Med Sci Spor Exerc 2009; 41: 459-471.
24. American College of Sports Medicine. Progression models in resistance training for healthy adults. Med Sci Spor Exerc 2002; 34: 364-380.
25. de Piano A, Prado WL, Caranti DA, Siqueira KO, Stella SG, Lofrano M, Tock L, Cristofalo DM, Lederman H, Tufik S, de Mello MT, Dâmaso AR. Metabolic and nutritional profile of obese adolescents with nonalcoholic fatty liver disease. J Pediatr Gastroenterol Nutr 2007; 44: 446-452. (Pubitemid 46573227)
26. Velasquez-Mieyer P, Neira CP, Nieto R, Cowan PA. Obesity and cardiometabolic syndrome in children. Ther Adv Cardiovasc Dis 2007; 1: 61-82.
27. Meyer AA, Kundt G, Lenschow U, Schuff-Werner P, Kienast W. Improvement of early vascular changes and cardiovascular risk factors in obese children after a six-month exercise program. J Am Coll Cardiol 2006; 48: 1865-1870. (Pubitemid 44648607)
28. Ćcero AFG Weight loss and blood pressure normalization: the relevance of early intervention in hypertension. Hypertens Res 2010 33 195-196.
29. Reaven GM. The metabolic syndrome: requiescat in pace. Clin Chem 2005; 51: 931-938. (Pubitemid 40740871)
30. Razani B, Chakravarthy MV, Semenkovich CF. Insulin resistance and atherosclerosis. Endocrinol Metab Clin N Am 2008; 37: 603-621.
31. Semenkovich CF. Insulin resistance and atherosclerosis. J Clin Invest 2006; 116: 1813-1822. (Pubitemid 44033301)
32. Okamoto Y, Kihara S, Ouchi N, Nishida M, Arita Y, Kumada M, Ohashi K, Sakai N, Shimomura I, Kobayashi H, Terasaka N, Inaba T, Funahashi T, Matsuzawa Y. Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice. Circulation 2002; 106: 2767-2770. (Pubitemid 35396973)
33. Reaven GM. Insulin resistance: the link between obesity and cardiovascular disease. Endocrinol Metab Clin N Am 2008; 37: 581-601.
34. Maher V, O'Dowd M, Carey M, Markham C, Byrne A, Hand E, Mc Inerney D. Association of central obesity with early carotid intima-media thickening is independent of that from other risk factors. Int J Obesity 2009; 33: 136-143.
35. Kotsis V, Stabouli S, Papakatsika S, Rizos Z, Parati G. Mechanisms of obesity-induced hypertension. Hypertens Res 2010; 33: 386-393.
36. Kelishad R, Hashemi M, Mohammadifard N, Asgary S, Khavarian N. Association of changes in oxidative and proinflammatory states with changes in vascular function after a lifestyle modification trial among obese children. Clin Chem 2008; 54: 147-153. (Pubitemid 351182608)
37. Steinbeck K, Baur L, Cowell C, Pietrobelli A. Clinical research in adolescents: challenges and opportunities using obesity as a model. Int J Obesity 2009; 33: 2-7.